Physician

Lara Kobrin, M.D.

According to 2025 Medicare claims, Lara Kobrin, M.D. (NPI: 1265811939) practices addiction medicine in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CMC DEPT OF MEDICINE GROUP PA (NPI: 1386682094; TIN: 223266219) and primary practice location at 08103-1438.

Kobrin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 29 traditional Medicare patients, billed 47 HCPCS/CPT codes, and received $4,534 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 487 prescription claims across 82 beneficiaries totaling $50,751 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). 2021 DME data shows 21 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $7,123 to $4,534. Similarly, Part D prescription costs have fallen sharply in recent years, from $2,996 to $50,751. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $914 to $653.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$19K$38K2018 Medicare payment: $7,123 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $19,846 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $31,068 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $37,572 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $8,792 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,534 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201869124$7,123
2019173372$19,846
2020192620$31,068
2021198795$37,572
2022113182$8,792
2023N/RN/RN/R
20242947$4,534

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$527K$1.1M2015 Drug cost: $2,996 (USD; Tot_Drug_Cst)2016 Drug cost: $13,526 (USD; Tot_Drug_Cst)2017 Drug cost: $83,365 (USD; Tot_Drug_Cst)2018 Drug cost: $136,428 (USD; Tot_Drug_Cst)2019 Drug cost: $368,385 (USD; Tot_Drug_Cst)2020 Drug cost: $778,086 (USD; Tot_Drug_Cst)2021 Drug cost: $1,054,928 (USD; Tot_Drug_Cst)2022 Drug cost: $292,182 (USD; Tot_Drug_Cst)2023 Drug cost: $53,820 (USD; Tot_Drug_Cst)2024 Drug cost: $50,751 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151953$2,996
201661232$13,526
2017101720$83,365
2018221945$136,428
20194462,088$368,385
20205433,893$778,086
20216495,996$1,054,928
20224093,417$292,182
2023118474$53,820
202482487$50,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$100$2002019 Medicare payment: $28 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $200 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R12$28
2020N/RN/RN/R
2021N/R21$200
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2434$78

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl1293,170$24,980
Buprenorphine HclBuprenorphine Hcl28441$962
Naloxone HclNaloxone Hcl1691$813
Albuterol Sulfate HfaAlbuterol Sulfate13321$453
Oxycodone HclOxycodone Hcl12211$261

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Lara Kobrin, M.D.?

Tedicare shows public-source Medicare data for Lara Kobrin, M.D. (NPI 1265811939), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lara Kobrin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lara Kobrin, M.D.?

Lara Kobrin, M.D. is linked to CMC DEPT OF MEDICINE GROUP PA (billing NPI 1386682094) in the available physician profile data.

Does Lara Kobrin, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.